Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System

@article{Karsak2007AttenuationOA,
  title={Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System},
  author={Meliha Karsak and Evelyn Gaffal and Rahul Date and Lihua Wang-Eckhardt and Jennifer Rehnelt and Stefania Petrosino and Katarzyna Starowicz and Regina Steuder and E. Schlicker and Benjamin F. Cravatt and Raphael Mechoulam and Reinhard Buettner and Sabine Werner and Vincenzo Di Marzo and Thomas T{\"u}ting and Andreas Zimmer},
  journal={Science},
  year={2007},
  volume={316},
  pages={1494 - 1497}
}
Allergic contact dermatitis affects about 5% of men and 11% of women in industrialized countries and is one of the leading causes for occupational diseases. In an animal model for cutaneous contact hypersensitivity, we show that mice lacking both known cannabinoid receptors display exacerbated allergic inflammation. In contrast, fatty acid amide hydrolase–deficient mice, which have increased levels of the endocannabinoid anandamide, displayed reduced allergic responses in the skin. Cannabinoid… 
View on AAAS
cannabisplus.net
264 Citations
Highly Influential Citations
7
Background Citations
83
Methods Citations
7
Results Citations
5

264 Citations

The Endocannabinoid System and Its Role in Eczematous Dermatoses

The role of endocannabinoids in maintaining skin health and homeostasis is highlighted and evidence on the role of ECS in several eczematous dermatoses including atopic dermatitis, asteatotic eczema, irritant contact dermatitis; and chronic pruritus is discussed.

Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis.

This review will integrate the recent advancement of immunological mechanisms of both the sensitization and elicitation phases of CHS into the classic view, and will discuss updated mechanisms on its development and future directions.

Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.

Regulatory Role of Cannabinoids for Skin Barrier Functions and Cutaneous Inflammation

Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone‐induced atopic dermatitis model

The effects of CBR agonists on skin inflammation, using acute and chronic inflammation animal models, are investigated.

The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders

The potential role of cannabinoids in dermatology

Cannabinoids have demonstrated anti-inflammatory, antipruritic, anti-ageing, and antimalignancy properties by various mechanisms including interacting with the newly found endocannabinoid system of the skin thereby providing a promising alternative to traditional treatments.

Anti‐inflammatory activity of topical THC in DNFB‐mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors

The mechanism of the anti‐inflammatory activity of THC and the role of CB1 and CB2 receptors are investigated and related cannabinoids are considered for the treatment of inflammatory skin diseases.

Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation

Results demonstrate that CB1 receptors are functionally expressed by KCs in vivo and help to limit the secretion of proinflammatory chemokines that regulate T cell–dependent inflammation in the effector phase of CHS.

Allergic Contact Dermatitis and the Endocannabinoid System: From Mechanisms to Skin Care

A therapeutic endocannabinoid-based strategy could be useful in numerous and diverse pathological conditions: mood and anxiety disorders, movement disorders, inflammatory and neuropathic pains, multiple sclerosis and spinal cord injury, cancer, atherosclerosis and cardiovascular diseases, stroke, glaucoma, obesity and metabolic syndrome, addictions, and osteoporosis.
...

References

SHOWING 1-10 OF 25 REFERENCES

Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity.

  • S. GrabbeT. Schwarz
  • Biology, Medicine
    American journal of contact dermatitis : official journal of the American Contact Dermatitis Society
  • 1996

Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice1

The results strongly suggest that the CB2 receptor and 2-AG play important stimulative roles in the sensitization, elicitation, and exacerbation of allergic inflammation.

The Endocannabinoid System in Human Keratinocytes

Unprecedented evidence is reported that spontaneously immortalized human keratinocytes partake in the peripheral endocannabinoid system and show a novel signaling mechanism of CB1 receptors, which may have important implications in epidermal differentiation and skin development.

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Most, but not all, CNS effects of Delta9-THC are mediated by the CB1 receptor, which accounts for the abuse potential of cannabis, while other effects such as analgesia suggest potential medicinal applications.

Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin.

Interferon inhibits the suppressor T cell response of delayed-type hypersensitivity

This work studied the effect of an electrophoretically purified mouse interferon (IFN-α and β) preparation on the Ts response to dinitrofluorobenzene (DNFB) in BALB/c mice and found that small amounts of the preparation inhibited the generation of Ts by DNBSO3 in vivo, and the function of Ts both in the recipient animals when injected i.v.

Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

A ligand/receptor relationship between AEA and CB1 in these two brain regions, where tonic activation of the receptor may tightly regulate the biosynthesis of its endogenous ligand is suggested.

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

  • M. IbrahimF. Porreca T. Malan
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 2005
Test the hypothesis that CB(2) receptor activation stimulates release from keratinocytes of the endogenous opioid beta-endorphin, which then acts at local neuronal mu-opioid receptors to inhibit nociception and indicates anatomical specificity of opioid effects.

The endocannabinoid signalling system: Biochemical aspects

Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.